BETWEEN: Biweekly Bevacizumab + Trifluridine/Tipiracil to Reduce Grade 3-4 Neutropenia in mCRC Patients
Clinical trial NCT07071844 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07071844
- Sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2028-12-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.